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Stigmatization as a Social 
Control Mechanism for Persons 
Living with HIV and AIDS
Judy E. Mill,1 Nancy Edwards,2 Randy C. Jackson,3 
Lynne MacLean,2 and Jean Chaw-Kant1
Abstract
Stigmatization contributes to inequity by marginalizing persons living with HIV and AIDS (PHAs). In this study we 
examined the stigmatizing practices in health care settings from the perspectives of PHAs and health care providers 
(HCPs). A qualitative design, using a participatory action research approach, was used. Interviews and focus groups 
were completed with 16 aboriginal and 17 nonaboriginal individuals living with HIV (APHAs and PHAs) and 27 HCPs 
in Ottawa and Edmonton, Canada. We present findings to support the premise that stigmatization can be used as 
a social control mechanism with PHAs. Participants described both active and passive social control mechanisms: 
shunning and ostracizing, labeling, and disempowering health care practices. Forgiving behavior, balancing disclosure, 
practicing universal precautions, bending the rules, shifting services, and reducing labeling were strategies to manage, 
resist, and mitigate social control.  The findings illustrate the urgent need for multilevel interventions to manage, resist, 
and mitigate stigma.
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Early in the AIDS epidemic Dr. Jonathon Mann, founder 
of the World Health Organization’s Global Program on 
AIDS, argued that AIDS was not strictly a medical con-
dition, but an illness with profound social, cultural, eco-
nomic, and political dimensions (Fee & Parry, 2008; Mann 
& Carballo, 1989). He referred to this phenomenon as the 
third AIDS epidemic, encompassing the denial, blame, 
stigmatization, and discrimination that HIV and AIDS 
evoke. The Panos Institute (1990) argued that the third 
epidemic has resulted in repercussions in virtually all societ-
ies affected by HIV, “challenging our compassion, our 
judgment, and our humanity” (p. ii). More than 20 years 
after Dr. Mann’s insightful comments, structural inequi-
ties such as poverty, racism, gender inequality, power 
imbalance, and sexual oppression continue to intersect and 
shape the HIV epidemic (Gupta, Parkhurst, Ogden, Aggle-
ton, & Mahal, 2008; Parker & Aggleton, 2003), and the suf-
fering caused by AIDS stigma and discrimination remain. 
This reality presents significant challenges to the develop-
ment of interventions for HIV prevention and AIDS care.
As illnesses, HIV and AIDS elicit profound stigma. 
Several of the attributes of HIV illness increase the likeli-
hood that its victims will be stigmatized: (a) the illness is 
viewed as the result of individuals violating the moral 
order of society (Alonzo & Reynolds, 1995; Mwinituo & 
Mill, 2006; Scott, 2009); (b) the contagiousness of HIV 
illness is perceived to threaten society (Mawar, Saha, Pan-
dit, & Mahajan, 2005; Mill, 2003); (c) HIV illness is 
viewed as a debilitating disease that results in death (Des 
Jarlais, Galea, Tracy, Tross, & Vlahov, 2006; Mill, 2003; 
Scott); (d) the symptoms of HIV illness become visible as 
the disease progresses (Hawkins, 2006); (e) it is transmit-
ted sexually (Mwinituo & Mill); and (f) HIV illness has 
most frequently been associated with groups already mar-
ginalized in society (Mawar et al.; Mill et al., 2009). AIDS 
stigma has the potential to influence health and health-
seeking behaviors in a variety of ways and, therefore, is an 
important consideration for health care professionals. For 
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example, stigmatized conditions might result in indi-
viduals and caretakers concealing their illness (Mill et al., 
2009; Mwinituo & Mill). Concealment, a behavior that 
enables persons living with HIV to have some control 
over their lives, has profound implications for the indi-
vidual, and in the case of stigmatized conditions that are 
infectious, has additional implications for public health 
(Des Jarlais et al.). 
Despite recognition early in the epidemic that “AIDS 
makes explicit . . . the complex interaction of social, cul-
tural, and biological forces” (Brandt, 1987, p. 199), AIDS 
stigma has long been conceptualized as a personal attri-
bute that evokes discrimination. The conceptualization of 
AIDS stigma must be broadened from the notion that 
stigma is a relatively static individual attribute to include 
recognition that it is “intimately linked to the reproduction 
of social difference” (Parker & Aggleton, 2003, p. 13), and 
is therefore ultimately a mechanism for social control. 
Furthermore, there is a need to understand how stigma 
influences professional and organizational practice and 
permeates health policy. This understanding must be 
predicated on the development and refinement of theory 
to describe AIDS stigma and discrimination (Campbell & 
Deacon, 2006; Deacon, 2006; Holzemer, Uys, Makoae, 
et al., 2007; Parker & Aggleton; Taylor, 2001). 
Early definitions of stigma reinforced the notion that 
stigma was an individual attribute. Goffman described 
stigma as “an attribute that is deeply discrediting” (1963, 
p. 13). The focus of stigmatization at the individual 
level is also seen in later definitions, including those of 
Alonzo and Reynolds (1995) and Siyam’kela (2006). 
These definitions provide some broadening of the concept 
of stigma, recognizing both emic and etic perspectives of 
the phenomenon. Despite this evolution, these theories 
still emphasized the individual with HIV or AIDS as the 
source of stigma, with limited attention to the structural 
inequities that influence the manifestation and experi-
ence of stigma. Parker and Aggleton (2003) argued that 
there has been very limited conceptualization of stigma 
beyond the individual level. Thus, there is a concentra-
tion of individually focused etiological and intervention 
research, with limited attention paid to the larger structural 
conditions that create exclusionary practices. Stigma 
has often been viewed as a negative element, mapped 
onto people rather than onto social institutions (Parker & 
Aggleton), reinforcing the perception that stigma is a 
static attribute rather than a social process. Although some 
recent work has acknowledged the wider social processes 
influencing stigma, there remains a tendency to revert 
back to an individualistic perspective on stigma. Holze-
mer, Uys, Makoae, and colleagues (2007) identified the 
need to describe the larger societal context of AIDS 
stigma in Africa; however, their discussion of the “stigma 
process” (p. 546) remains rooted in an individualistic 
approach. 
Several authors have critiqued conceptualizations of 
stigma that focus primarily on the individual level in rela-
tion to AIDS (Parker & Aggleton, 2003; Yang et al., 
2007), diabetes (Aikins, 2006), and hepatitis C (Paterson, 
Backmund, Hirsch, & Yim, 2007). Parker and Aggleton 
provided a compelling case for expanding the conceptu-
alization to include the political and societal dimensions 
of stigma, and to reflect power dimensions that are at play 
in society. In relation to HIV status, stigma reflects ineq-
uitable power relations that are “created and sustained 
to legitimize dominant groups in society” (International 
Federation of Red Cross and Red Crescent Societies, 
2004, p. 70). Parker and Aggleton described stigmatiza-
tion as “culturally constituted” and “central to the estab-
lishment and maintenance of social order” (p. 17). Similarly, 
Taylor (2001) argued that “stigma serves to reinforce 
social norms by defining deviance” (p. 794), thereby pro-
moting inequity by marginalizing an individual or group 
from the rest of society. 
Campbell and Deacon (2006) argued that conceptual-
izations of stigma must merge both the individual and 
social dimensions of stigma, rather than predisposing 
toward either dimension. The authors provided a critique 
of individualistic explanations of stigma; however, they 
cautioned that focusing only on the macrolevel analysis of 
stigma might result in the individual psychological dimen-
sions receiving inadequate attention. Therefore, they 
proposed a conceptualization of stigma that “straddles 
individual and macro-social analysis” (p. 412) to ensure a 
more comprehensive understanding of the phenomenon. 
They suggested that although stigma is embedded in the 
individual psyche, it is continually influenced by material, 
political, institutional, and symbolic contexts.
Illnesses, and particularly those that are considered 
the result of deviant behavior (e.g., AIDS, leprosy), rep-
resent a threat to the established order of society (Freund 
& McGuire, 1998). Shapiro argued that from a Western 
biomedical perspective, “the role of medicine is to con-
tain and manage the potential chaos of illness from over-
whelming the social fabric” (2008, p. 3). Social control 
mechanisms such as stigma therefore assist in maintain-
ing societal order. For example, health care providers 
(HCPs), in positions of power, influence the labeling of 
deviance and the establishment of social norms (Freund 
& McGuire). 
Individuals already marginalized in society, and who 
develop a stigmatizing condition such as HIV infection, 
might experience a layering or double burden of stigma 
(Duffy, 2005; Mill et al., 2009; Mill, 2001; Reidpath & 
Chan, 2005; Weiss & Ramakrishna, 2001). Indigenous 
peoples worldwide have a history of being disadvantaged 
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and marginalized within both poor and wealthy countries, 
with consistently poorer health outcomes than their non-
indigenous counterparts in the same country (Gracey 
& King, 2009; Stephens, Porter, Nettleton, & Willis, 
2006). In the Canadian aboriginal population, the long 
history of racism, marginalization, colonization, and dis-
enfranchisement (Adelson, 2005; King, Smith, & Gracey, 
2009; Larkin et al., 2007; Pearce et al., 2008) has resulted 
in a greater likelihood that if HIV positive, they will 
experience a layering of stigma. Reidpath and Chan sug-
gested that “there needs to be an understanding of the 
layering of stigma so that informed policies and interven-
tions can be developed that will address the entire experi-
ence of stigma” (p. 431). Aboriginal people might be 
differentially impacted by HIV infection because of vary-
ing cultural constructions of stigma; differing beliefs 
about health, illness, and healing; and the burden of hav-
ing more than one attribute that evokes stigma (Weiss & 
Ramakrishna). 
In Canada, aboriginal peoples experience a high bur-
den of disease and social suffering (Adelson, 2005; 
Larkin et al., 2007); it is estimated that the HIV infection 
rate among the Canadian aboriginal population is 2.8 
times higher than among nonaboriginal persons (Boulos, 
Yan, Schanzer, Remis, & Archibald, 2006). Although 
only 3.8% of the Canadian population report aboriginal 
ancestry (Statistics Canada, 2008), in 2006 aboriginal 
persons made up 24.4% of AIDS cases for which ethnic-
ity was known (Public Health Agency of Canada, 2007). 
Adelson argued that the health disparities experienced by 
the aboriginal peoples in Canada are the “embodiment of 
inequity” (p. S45), and that these disparities are related to 
economic, political, and social inequities, including lim-
ited autonomy. 
Das argued that “discourses on stigma are deeply impli-
cated in the fault lines of racism, sexism and other forms 
of discrimination” (2001, p. 9). For example, poverty 
might magnify and drive the stigmatization of persons 
living with HIV and AIDS (Campbell, Nair, Maimane, & 
Nicholson, 2007; Masanjala, 2007), limiting one’s ability 
to resist stigma (Campbell & Deacon, 2006). The phenom-
enon of layered stigma suggests that stigma might follow 
the path of existing fault lines (Campbell & Deacon); how-
ever, it might also create new ones (Deacon, 2006). 
The notion that some groups in society are less vulnera-
ble to stigma than others was explored with HIV-positive 
women who were not considered marginalized, but rather, 
possessed one or more signs of “symbolic capital,” includ-
ing being White, heterosexual, educated, and/or middle 
class (Grove & Kelly, 1997). Symbolic capital provided 
some protection against stigma. 
The purposes of our current study were (a) to explore 
stigmatizing practices in health care settings from the 
perspectives of PHAs, APHAs, and HCPs; (b) to develop 
an optimal design for health service delivery to eliminate 
stigmatizing practices; and (c) to describe the process 
required to reorient health services to incorporate the 
optimal design. In this article we present findings related 
to the first purpose of the study. The findings related to 
the second and third purposes will be the subject of a 
future article. Based on the analysis of the stigmatizing 
practices that PHAs and APHAs encountered when 
accessing health care settings, we argue that stigma can 
be conceptualized as a social control mechanism that is 
used implicitly or explicitly by individuals, organiza-
tions, and society. 
Methods
A qualitative design, using a participatory action research 
(PAR) approach was used for the study. This approach 
facilitates consciousness raising and promotes critical 
thinking in individuals and communities to explore the 
root causes of their situation (Schoepf, 1994). The tenets 
of PAR are congruent with the essential principles for the 
conduct of research with aboriginal communities: owner-
ship, control, access, and possession (OCAP; Patterson, 
Jackson, & Edwards, 2006); the protection of indigenous 
knowledge (Battiste & Henderson, 2000); consideration 
of ethical implications for individuals and communities 
(Kaufert et al., 2001); and the adherence to community-
controlled collaboration (Smylie et al., 2004). Throughout 
the research process, several strategies were used to 
develop and maintain a collaborative relationship with our 
community partners. In Edmonton, ethical approval was 
obtained from the Health Ethics Review Board (Panel B) 
at the University of Alberta, to access sites in Edmonton. 
In Ottawa, ethical approval was obtained from the Ottawa 
hospital, general site, and the University of Ottawa. 
After ethical approval was obtained, community advi-
sory committees were formed at each site to advise on the 
implementation process, cultural appropriateness of guid-
ing questions, and dissemination strategies for the study. 
The community advisory committees included PHAs and 
APHAs; and representatives from aboriginal communi-
ties, agencies offering services to PHAs and APHAs, and 
consumer groups representing PHAs and APHAs. Terms 
of reference for the community advisory committees were 
developed by the research team in consultation with the 
community advisory committee members.
Community consultation workshops were another strat-
egy used to engage our community partners. Following 
preliminary data analysis, 1-day workshops were held 
with 97 participants in three Canadian cities. The par-
ticipants included PHAs, APHAs, community advisory 
committee members, HCPs, representatives from AIDS 
 at UNIV OF WESTERN ONTARIO on August 29, 2012qhr.sagepub.comDownloaded from 
1472  Qualitative Health Research 20(11)
service organizations, decision makers, and research team 
members. The purpose of the workshops was to engage 
decision makers and HCPs in the design of an interven-
tion to reduce AIDS stigma in health services for PHAs 
and APHAs. During the workshops, members of the 
research team provided an overview of key findings from 
the research project, and then workshop participants were 
asked to assist with the design of an intervention. Best-
practice guidelines (Mill et al., 2007) for the provision of 
services to PHAs and APHAs were an outcome of this 
process, and will be published separately.
A multiorganizational design was used to enhance our 
understanding of the context of AIDS stigma in different 
settings. Convenience and network sampling (Wood & 
Ross-Kerr, 2006) were used to recruit aboriginals and 
nonaboriginals to participate in an interview in the cities 
of Edmonton and Ottawa, Canada. Aboriginal partici-
pants included individuals who identified as Métis, First 
Nations, or Inuit, regardless of treaty status (Ermine, 
Sinclair, & Jeffrey, 2004). At each site, four health care 
organizations representing small and large organizations, 
using a range of approaches to health care delivery (e.g., 
acute care, primary health care), and providing access to 
aboriginal populations were selected to assist with 
recruitment of PHAs and APHAs. This helped to ensure 
that aboriginal peoples, who are overrepresented in the 
HIV and AIDS statistics (Public Health Agency of Can-
ada, 2007), were included in the sample. The eligibility 
criteria for PHAs and APHAs required that participants 
be more than 18 years of age; agree to participate in the 
study; speak English or French; be HIV positive; not 
currently be an inpatient; had lived in Canada for at least 
3 years; and had accessed health services (e.g., medical, 
dental, laboratory, x-ray, counseling) within the previous 
2 years. 
A contact person at each organization approached 
potential participants who met the eligibility criteria to 
ask if they were interested in participating in the study. 
Information letters were provided to potential participants, 
who were asked to contact the research coordinator. 
Open-ended interviews with PHAs and HCPs were con-
ducted primarily by the research coordinator at each site, 
and focus groups with HCPs were carried out by two 
members of the research team in one of the participating 
organizations. Informed consent was obtained from all 
participants. The contact person at each of the participat-
ing organizations was consulted to determine if interviews 
or focus groups for the HCP would be preferable. Inclu-
sion criteria for the HCPs required that they be English or 
French speaking, a health professional or community 
worker in one of the organizations participating in the 
study, and agree to participate in the study. Guiding ques-
tions were prepared to assist the interviewer to focus the 
interviews on the experiences of the participants in rela-
tion to stigma and to maintain a balance between consis-
tency and flexibility (May, 1991). The HCPs were asked 
to reflect on the themes emerging from the interviews 
with APHAs and PHAs in relation to stigmatizing prac-
tices; however, HCPs were not asked to comment on social 
control mechanisms. Concurrent with the interviews and 
focus groups with HCPs, the policies and practices of 
organizations were also examined to identify those that 
might promote or inhibit AIDS stigma. The document 
analysis was carried out to uncover the perspectives and 
priorities of each of the participating organizations in 
relation to the care and treatment of persons with HIV. 
Document analyses are appropriate for gathering infor-
mation about the context for implementing new policies 
or practices (Murphy, 2001).
An inductive approach was used to analyze the data 
from the PHA and APHA interviews and involved coding 
and identifying categories and themes and discovering and 
disconfirming relationships among themes via systematic 
comparisons using matrices, negative cases, and extreme 
cases. The focus groups and interviews with HCPs were 
similarly analyzed, and findings compared to the issues 
emerging from the data from PHAs and APHAs. During 
the initial, descriptive analysis of the study findings, the 
AIDS stigma experienced by participants often intersected 
with other forms of stigma related to behavior, culture, 
gender, sexual orientation, or social class, and organiza-
tional policies contributed to and intersected with indi-
vidual stigma (Mill et al., 2009). An in-depth conceptual 
analysis of the findings revealed that the PHAs and 
APHAs experienced shunning, ostracization, labeling, 
and disempowering practices when accessing health care 
services. The conceptual analysis of the data was carried 
out iteratively with a process of theorizing, as described 
by Morse (1994). Theorizing refers to the process of 
interpreting the data in the context of relevant theory, and 
involves the “systematic selection and fitting of alterna-
tive models to the data” (Morse, p. 33). Based on our 
theorizing, we argue that the experiences and practices 
encountered by participants when accessing health ser-
vices are mechanisms for social control. In this article, 
illustrative quotes (using pseudonyms, and with refer-
ences to sites and place names removed) are used to high-
light the social control mechanisms.
Findings
Thirty-three HIV-positive individuals (16 aboriginal and 
17 nonaboriginal) participated in an in-depth interview. 
The aboriginal identity of the APHAs included First Nations 
(10), Métis (3), Inuit (2), and unknown (1). Twenty-two men, 
9 women, and 2 transgender individuals participated, and 
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ranged in age from 31 to 56 years (mean 40.6 years). The 
primary modes of HIV transmission for the sample were 
injection drug use (IDU; n = 17) and men who had sex 
with men (n = 16). Twenty-seven HCPs, including physi-
cians, nurses, social workers, psychologists, and a dentist 
participated in an in-depth interview (20) or a focus group 
(7). Three of the HCPs were men and 24 were women; 
2 of the 27 HCPs were aboriginal. All of the HCPs 
had experience in acute care or community settings, and 
explained that a personal connection to the area of HIV 
and AIDS was a reason for their current work involve-
ment. Several HCPs reported that their initial experience 
in HIV began through student practical placements or 
professional training placements. 
All of the interviews and focus groups were conducted 
in English over a 1-year period of time and took place 
in one of the participating organizations. The interviews 
lasted approximately 1 hour, whereas the focus groups 
lasted approximately 2 hours. Participants described their 
experiences of stigma and stigmatizing practices in a 
variety of social situations involving family members, 
friends, and coworkers, and in interaction within social 
institutions including health care settings, prisons, shel-
ters, and workplaces. HCPs described stigmatizing prac-
tices in the health care institutions where they worked, 
and to a lesser extent in other health care institutions pro-
viding services for their clients. The specific social con-
trol mechanism that was introduced through a particular 
institutional policy was often coupled with other factors 
that worsened clients’ experiences of stigma. Social and 
institutional controls were encountered by APHAs and 
PHAs on a regular basis, taking both positive and nega-
tive, and overt and covert forms. Although both nonab-
original and aboriginal participants employed a variety of 
strategies to manage stigma, aboriginal participants used 
additional cultural approaches (e.g., connecting with elders, 
participating in ceremonies) to mitigate the negative impacts 
of stigma. These approaches in turn influenced the uptake 
of “healthy” coping strategies (e.g., establishing and 
rebuilding trust in HCPs and health care organizations). 
Although an important finding, the focus of our analysis 
for this article was not a comparison of aboriginal and 
nonaboriginal experiences related to social control; the 
experiences of aboriginal participants will be discussed 
in greater detail in a forthcoming article. 
Exerting Social Control
Shunning and ostracization. Shunning and ostracization 
were commonly cited social control mechanisms that 
were both intentional and unintentional. These controls 
occurred in many settings and with many individuals, 
ranging from family members to HCPs and prison workers. 
For example, several of the participants noticed changes 
in how they were treated at work, and/or in what their 
responsibilities were following disclosure of their HIV 
status. Kory was no longer allowed to assist with the prep-
aration of food:
I was working part time when I first found out. I 
was helpin’ out at an AA [Alcoholics Anonymous] 
club and I noticed, because my boss didn’t want the 
older members to find out, my duties in the kitchen 
got cut: there was no more cooking. They were 
scared in case I cut myself and stuff like this.
Quinn, on the other hand, was required to wear addi-
tional “protective” clothing that made him feel ostracized 
by other staff:
They made me wear gloves. I mean the other staff 
I saw they would do that. They wouldn’t wear 
hairnets, stuff like. And they made me dress up 
like some sort of space person [laugh]. Because 
they thought, “Oh this person!” I just felt very 
ostracized. 
The shunning and ostracization that PHAs and APHAs 
experienced were intricately linked with shunning because 
of other characteristics. Most participants experienced a 
layering, or a double (or triple) burden of stigma because 
they had become infected through a behavior that was 
highly stigmatized (e.g. IDU, commercial sex work); 
belonged to a culture (aboriginal), gender (women), or 
social class (poor, prisoner) that was vulnerable to stig-
matization; or suffered from another illness (e.g., mental 
illness) that was stigmatized. Feeling shunned because of 
sexual orientation was described by several participants, 
particularly gay men. Some participants, therefore, chose 
to keep their sexual orientation and their HIV diagnosis 
secret because of a fear of being shunned by family, 
friends, and HCPs:
There’s a lot of AIDS jokes and gay jokes, and 
hatred and bigotry, so it’s better to keep it hidden 
and keep it to yourself and then you won’t get 
picked on, or ostracized, or shunned. You could get 
shunned or ostracized very quickly by a group of 
people, and then sit around and watch who comes 
to socialize with you.
Several of the participants commented on the layered 
stigma they endured as aboriginal, HIV-positive indi-
viduals. Nolan referred to this as “the stigma within the 
stigma,” and recalled being labeled as “another drunken 
Indian . . . a faggot drunken Indian.” Fred was also aware 
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of having experienced layered stigma. He recalled that “it 
was really kind of like a black labeling. I just didn’t want 
to be put in that category [HIV] because I was already 
dealing with a lot of others issues, one being Native, two 
being in jail.” One of the HCPs provided strong evidence 
of institutional shunning, especially in facilities that did 
not routinely see clients with HIV:
If they go to a facility or place that doesn’t routinely 
provide care to HIV-positive people, then it’s like 
there is this level of discomfort that the staff have 
’cause they don’t do it on a day-to-day basis, so they 
don’t think about how their behavior might make a 
person feel. 
Kelly was not prepared to disclose her HIV status when 
she was in prison because of the shunning she had 
observed toward others:
I wasn’t ready to address my HIV because of the 
simple fact that I’d seen other girls in the system 
[prison] being shunned from having friends and 
going out and doing things, and it was awful. And 
I knew I had this deep little dark secret behind me 
that I was sick. 
Shunning carried a high risk for HIV-positive individuals 
because it could result in limited social support, highly 
vulnerable living situations, and lack of access to required 
care, ultimately making it more difficult for participants 
to manage their illness.
Labeling. Labeling was also a fairly common practice 
that marginalized persons living with HIV. At the time of 
the interview, Ethen was no longer using cocaine; how-
ever, he was still being treated as an addict by HCPs. This 
influenced the care he received, particularly in relation to 
pain relief:
I find the medical profession treats me [first] like 
an addict, and then like a patient. “Okay, you’re 
an addict, so we’re not going to prescribe any-
thing to you that’s a narcotic.” It’s very frustrat-
ing. Yes, I was an addict. No, I’m not an addict 
anymore. Yes, I do have legitimate pain. 
Labeling occurred when clients presented with comor-
bidities or had complications arising from AIDS. When 
hospitalized for pneumonia, Kelly felt that the color of the 
gown that she was given labeled her as being infectious:
At one time, because I had such a bad cough, they 
put me in a yellow gown and I guess that yellow 
gown means I was in a certain kind of room all by 
myself [laughs]. I didn’t like that treatment, because 
I felt like I had [laughs] something that nobody else 
had in the whole hospital. I just felt like nobody 
would come near me. And then they found out that 
I didn’t have TB, so then they put me in a different 
gown and I could leave my door open.
Aaron recalled being labeled by a nurse who assumed 
that his HIV status was synonymous with being gay:
I have Kaposi’s [sarcoma] on my left foot, on my 
large toe, and Kaposi’s—it looks like a big, black 
bruise—and so she [nurse] asked me what it was 
and I explained it to her, and she said, “Why are 
your toenails painted?” And I looked at her and 
I said, “Well, they’re not. That’s part of the ill-
ness.” And she said, “What?” And I explained to 
her, I said, “Well,” and I kept my voice down, and 
I said, “Well, I’m HIV positive,” and she walked 
out to another nurse and she said, “Why didn’t you 
tell me there’s a fag in there that has AIDS?”
Participants described situations when their HIV-
positive status labeled them. For example, Dennis had 
the following experience when he was in prison:
They had a like a day timer board [clip board] on the 
table, and if you looked at it you could see every-
body’s name and assigned cell. Well, above the ones 
that were positive they had “HIV positive” written. 
You know? Hell!
In some health care settings, “caution sheets” were 
placed on patient’s charts to alert HCPs that a patient was 
HIV positive. Charles, a physician, believed that caution 
sheets contributed to stigma and were not necessary:
It contributes to the stigma and fear piece. Like, 
all of a sudden there’s this glaring caution sheet as 
soon as you flip the chart, and you go, “Oh, cau-
tion. What should I be looking out for?” Usually, 
they’re used for allergies, sensitivities, or then 
you look down and see they’re HIV. To me, it’s a 
question of, why does this need to be on the front 
of the chart?
A few participants recalled feeling comfortable in set-
tings that did not “label” them. Cecil found it very com-
fortable at one AIDS service organization: “I like it here. 
It’s nice. I mean, you feel kind of safe, you know, it’s—
people know what you’ve got. Nobody attaches, puts a 
sign on your back. It feels comfortable; a comfortable 
feeling around here.”
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Participants were very sensitive about receiving spe-
cial privileges or accessing services that would identify 
them as HIV positive. Several felt uncomfortable receiv-
ing special foods or additional food when in a shelter or 
prison. This practice could identify them as being HIV 
positive and put them at risk of being ostracized: 
You don’t get support in jail as far as I’m concerned. 
If you’re HIV [positive] you get a double meal as 
soon as you walk into the jail. They say, “Are you on 
a diet or a special diet?” And if you say yes, then 
everybody knows on an arranged diet you’re HIV 
positive. 
Explicit signage on HIV clinics made it awkward to 
enter or approach the site for some participants, whereas 
others experienced no difficulty. Dennis had concerns 
that his diagnosis became public when he accessed an 
HIV clinic:
Having this sign glowing at the top of our building 
is appalling to me. I don’t think that we need to 
put “HIV” up at the front of our building. We 
don’t need that. People need to be able to come in 
and out of here without that stigma being attached 
to them. 
Disempowering Health Care Practices
Social control was also exerted through disempowering 
health care practices. Several of the participants spoke of 
situations in which they were excluded, directly or indi-
rectly, from the decision making about their life choices 
or their health care. This practice compromised the trust 
that PHAs and APHAs had in their HCPs, and resulted in 
feelings of disempowerment. Participants shared stories 
of HCPs who did not ask for consent to carry out an HIV 
test; judged clients based on their physical appearance, 
HIV or Hepatitis C status; made assumptions about who 
to share the client’s HIV status with; pressured them to 
change their lifestyle; or used universal precautions inap-
propriately. Alfred was not consulted by his physician 
prior to having an HIV test:
They tested me for everything. But they never 
asked me if I wanted an HIV test. I was really 
sick, and I’ve never been that sick before in my 
life. So, uh, they did the HIV test, I guess, at one 
point or another.
One HCP reported that in her experience, if a patient did 
not give consent for an HIV test, it would often be done 
anyway on previously collected blood:
Well, then it goes above their head, kind of thing, 
’cause it has to be done. It’s consent if, we prefer 
you to say yes, [laughs]. Then we have to go through 
other channels, yeah, because we probably already 
have some blood of yours anyways. So even if they 
refuse to let us poke again, there’s something up in 
the lab. 
Another HCP noted that pregnant women were often not 
asked for consent to be tested for HIV, a practice that 
contradicts Canadian standards for informed consent: 
“When they find out you’re pregnant, automatically 
would do an HIV test. They actually are supposed to ask 
consent; the thing is they usually don’t. The test is just 
done. And that’s very bad, because there’s no pretest 
counseling.”
Some participants did not believe that they were equal 
partners in decisions about their health, or were judged 
based on their appearance when accessing health services. 
Jenny was very resentful of the approach used by some 
HCPs to try to convince her to give up her use of intrave-
nous drugs. She recalled feeling pressured by a nurse:
To give up my sets, my needles, and all the time 
I said, “Listen, you can sit here and preach to me 
until you’re black and blue in the face, but I’m not 
ready. I’ll tell you that right now. I am not willing 
to give up the needle. And nobody can make that 
decision except me.” I said, “I’m in control of it, 
and I’m not ready to quit, so don’t even come tell 
me.” And the nurse, like, and one of these type 
people, trying to help people, and get them clean 
and straight and all this fuckin’ bullshit. 
Despite the pressure, Jenny felt that she needed to maintain 
control of the decision to quit drugs. Oliver had not been 
consulted prior to the physician telling his sister that he 
was HIV positive. After learning about Oliver’s HIV 
status, his sister told many others:
Another doctor had accidentally told her [sister] 
about me, and I thought, “What are you telling 
her this for?” And he [doctor] said, “Well, she’s 
your sister. Aren’t you close?” And I said, “Not at 
all! I don’t trust her. If there’s anybody on this 
planet I wouldn’t tell, it’s her! Now everybody is 
gonna know! She’s already blabbed vital infor-
mation about me.” 
Some PHAs and APHAs described feeling judged when 
they accessed care, based on their appearance. Bob tried 
to minimize discrimination when he accessed health 
services by taking great care with his appearance: 
 at UNIV OF WESTERN ONTARIO on August 29, 2012qhr.sagepub.comDownloaded from 
1476  Qualitative Health Research 20(11)
Because I was so anxious to avoid it [stigma], 
I would be dropping in, in a shirt and tie, relatively 
presentable, and I think that in itself might make it 
a little bit different than somebody who has, you 
know, come from the street. I think still for most of 
us one’s appearance makes a big difference. And so 
perhaps that might be another reason why I might 
have been fortunate there.
The inappropriate use of universal precautions was 
an institutional control that isolated and disempowered 
individuals living with HIV. For example Ethen, a PHA, 
experienced differences in the approach to universal pre-
cautions depending on where he accessed health ser-
vices. He recalled visiting a small town for the treatment 
of a lung infection: “I had better care there than I ever 
received in the city. There was no freaking out. There 
was none of this, ‘Quick, get [the] gloves.’” Wilma, a 
community development worker, commented that nurses 
had used excessive infection control precautions when 
her friend’s HIV-positive brother had gone to a major 
hospital for treatment:
The nurses were standing there, and they had this 
disgusting look on their face, and gloving up, and 
gowning up and everything, masking up. I’m sure 
if they could have gone in there with some kind of 
space suit, they probably would have. So you kind 
of wonder what happened to those people and 
compassion. 
Jon recalled troubling situations when excessive universal 
precautions were used with friends:
I know a lot of people who have come in, or gone 
home to visit family and gotten sick, and had to go 
to the emergency [department] in their local town, 
and all of a sudden they find out they’re positive, 
they’re almost like pariahs. They [health care work-
ers] triple glove themselves. And they do this in 
front of the people. And these are professionals.
Managing, Resisting, and 
Mitigating Social Control
Efforts to manage, resist, and mitigate social control mech-
anisms were described by participants. PHAs and APHAs 
often forgave stigmatizing behaviors, and carefully con-
sidered to whom they disclosed their HIV status and exactly 
what to disclose. The practice of universal precautions 
and the ability to bend the rules and shift the services 
were considered essential to the provision of respect-
ful, nondiscriminatory care. Strategies to reduce labeling 
were also important. 
Forgiving behavior. Almost half of the participants pro-
vided justification for the shunning and stigmatizing 
behaviors they encountered. They understood and even 
forgave these behaviors for a variety of reasons: it was 
natural for individuals to be nervous about HIV because 
of its infectivity; it might be the HCPs’ first experience 
with HIV; it was a new disease; or the HCP was not ready 
to care for a person living with HIV:
She was just a walk-in clinic type doctor. And new, 
young, family oriented. And I think she had her 
strong suspicions of my sexuality, and that plus my 
new diagnosis. No. She wasn’t ready, which was 
fair of her, but I felt discriminated against a bit. 
I was hurt a little bit. 
In some instances, participants made no attempt to cor-
rect discriminatory practices because they felt it might be 
difficult for the HCP to manage their care. Participants 
not only had to deal with a stigmatizing practice from an 
HCP, but were up against a set of well-entrenched stig-
matizing institutional practices. 
Balancing disclosure. Participants described various per-
mutations of disclosure, sometimes in collusion with 
HCPs, as a means to manage stigma. For example, some 
participants disclosed their hepatitis C but not their HIV 
status to ensure the use of universal precautions, and at the 
same time decrease the likelihood of stigma: 
He [doctor] told me if I ever go to the hospital or 
anything else just tell them I have hepatitis C, do not 
tell them I have HIV. But then when I tell them I have 
HIV they completely turn; they’re not the same kind 
of people. They don’t even want to touch you.
Participants described disclosing their HIV status to 
family and friends using approaches to normalize the 
diagnosis. Dennis was able to “slide” his HIV diagnosis 
into the conversation: 
To me it wasn’t a big deal. Nine years of living with 
someone that already had it, it wasn’t, you know, 
new news to anybody about, you know, what it is or 
how it’s spread. They were all educated by then, so 
it was quite easy for me to just sort of slide it in 
there and, you know, just go about things. 
Practicing universal precautions. The consistent use of 
universal precautions was seen by PHAs, APHAs, and 
most HCPs as a key factor to mitigate stigma. They believed 
that if universal precautions were used with all patients, 
the use of protective apparel would not identify them as 
HIV positive. Despite this finding, participants described 
situations when their medical record clearly identified 
 at UNIV OF WESTERN ONTARIO on August 29, 2012qhr.sagepub.comDownloaded from 
Mill et al. 1477
them as HIV positive, yet HCPs failed to use universal 
precautions. Kory, a PHA, felt chastised when a nurse did 
not use gloves: “She put an IV or something in me with-
out gloves, and she flipped. That hurt because I felt like 
I did something wrong, but it’s all over my file, like I don’t 
hide it.” The selective use of gloves by HCPs was seen as 
stigmatizing, and at the same time the lack of gloves was 
viewed as poor practice because of the risk of infection to 
both the patient and the HCP. It was not helpful when 
HCPs failed to use universal precautions in an attempt to 
demonstrate their comfort with persons living with HIV 
and AIDS. Carmen commented on the challenges she had 
experienced in deciding when to wear gloves:
Like, if you’re not wearing gloves before you go in 
to see someone, and someone sees you, you’re 
often, like, “What are you doing? Put your gloves 
on.” We don’t go in and chart, do vitals with gloves 
on, necessarily, ’cause I find that very impersonal, 
and people-stand-offish. You know, like, “What 
does she think I have?” Like, “Oh, my God, what’s 
wrong with me?” 
Bending the rules. Several of the HCPs spoke about the 
need to “bend the rules” when providing care to persons 
living with HIV. Charles commented that his organiza-
tion bent the rules to enhance access:
Officially, you cannot participate in a program or 
you can’t even attend that program if you’re intoxi-
cated, so that’s been a bit of an issue for me. There-
fore, that strict policy piece is being relaxed; we’re 
bending the rules a little bit.
Although caregivers provided a number of examples of 
how they relaxed institutional policies in an effort to cre-
ate a less-stigmatizing environment, clients still perceived 
this as controlling behavior on the part of the caregiver. It 
was usually the caregiver and not the client who made the 
decision about whether or not to relax policies. One HCP 
stated that his approach to care emphasized working with 
the client based on the client’s life and circumstances at 
the time. He encouraged clients to express their prefer-
ence regarding HIV testing:
I make it a policy of never trying to tip the balance 
one way or another in pushing someone one way or 
another to either decide to get tested or not to get 
tested. So it would be them talking their way to that 
on their own. 
Shifting services. Health care providers commented on 
the necessity to expand and shift services for persons liv-
ing with HIV to ensure that clients’ needs were met and 
care was continuous. Several HCPs commented on the 
growth and evolution that had taken place within the 
organizations they worked in: 
As we’ve grown as an organization, and as we’ve 
become stable, there’ve been changes in the clinic. 
Yeah, I’d say it’s more evolved from a nurse practi-
tioner point of view. We’ve tried to institute changes 
that lead to more continuity of care, so that’s one 
way. And we’ve tried to sort of work at becoming 
more of a team, so the communication between 
providers I think has probably increased.
Sandra described her organization’s multidisciplinary 
approach to patient care, and her efforts to provide client-
centered care to establish trust:
We’re all committed to the clients. We kind of 
decided that it would work out better if I went to 
see them. And then with the street clients, when I 
first started, I knew that a large percentage of our 
clientele were street people, and they don’t like 
coming to the hospital; they’ve had bad experi-
ences in the hospital. And I started these [outreach 
groups in inner city agencies] shortly after I started 
here. And that was to be where the street people are 
so that they can get to know me in their environ-
ment, and it worked! It worked.
Our document review revealed that institutional policies 
and procedures did not overtly encourage stigmatization; 
however, HCPs used discretionary practices in an attempt 
to mitigate stigma. Within the larger social context, HIV 
disease was still stigmatized. Therefore, even when 
organizations and HCPs attempted to put destigmatizing 
practices in place, they could inadvertently become 
stigmatizing within the larger social or health care system. 
Reducing labeling. The ability to access HIV care ser-
vices without being labeled as HIV positive was seen to 
be very important from the perspective of the HCPs. Var-
ious institutional efforts were made to try and reduce the 
likelihood of labeling. For example, a variety of services 
were provided in the same setting:
When we ask them [clients] to give us a couple of 
snapshots of what they thought of our service, they 
always tell us they like the fact that no one can label 
them as having HIV just because they’ve seen them 
here. A lot of them wouldn’t come in if seeing 
them here would mean that everyone else that 
saw them here would know they had HIV.
Clients were often aware of ways in which they might 
report stigmatizing experiences in the health care setting; 
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however, they often decided not to report stigmatizing 
experiences because this might jeopardize their relation-
ship with the HCP. 
Discussion
Our findings from the current study document the use of 
stigmatization as an institutional and social control mech-
anism that contributes to the marginalization of persons 
living with HIV and AIDS. The experiences of PHAs and 
APHAs provide exemplars of social control mechanisms 
that were sometimes explicit, and other times subtle. When 
viewed in their entirety, the findings provide a potent illus-
tration of the inequitable power differentials and social 
control mechanisms referred to by Parker and Aggleton 
(2003) in their conceptualization of stigma. Conceptual-
izations of stigma must also account for the human capac-
ity for agency, and allow for the possibility of resistance 
and change (Campbell & Deacon, 2006; Howarth, 2006). 
Our findings support this dimension of stigma theory by 
highlighting strategies that both persons living with HIV, 
and those providing care for them, employed to manage, 
resist, and mitigate social control mechanisms, thereby 
attempting to reduce stigma.
The labeling associated with the diagnosis of HIV or 
AIDS serves as a social control mechanism to distance the 
infected from the uninfected. Mawar and colleagues 
(2005) argued that labels such as “risk group” and the 
“general public” help to distance “them” [the infected] from 
“us” [the uninfected]. Similarly, Sontag (2001) argued 
that an HIV positive diagnosis “separates the sick from 
the well” (p. 116) and labels the individual as “seemingly 
healthy but doomed” (p. 119). Scott (2009), in interpreting 
the illness meanings of AIDS, described it as “deeply dis-
crediting [and] . . . a visible state that marks physical fail-
ure, moral failure, and social ostracism” (p. 464). The 
themes of shunning and labeling highlighted in the current 
study are comparable to some of the constructs identified 
by researchers for the measurement of stigma. An Inter-
nalized AIDS-Related Stigma Scale developed by Kalich-
man and colleagues (2009) included items to measure the 
endorsement of social sanctions (e.g., restriction on free-
dom and isolation) toward persons living with HIV. The 
AIDS Stigma Scale developed by Berger, Ferrans, and 
Lashley (2001) included the factor “concern with public 
attitudes about people with HIV” as one of four factors 
in the scale. Similarly, an AIDS stigma instrument devel-
oped in five African countries by Holzemer, Uys, Chirwa, 
and colleagues (2007) included social isolation and ver-
bal abuse as factors in the stigma measure. The overlap of 
themes in our qualitative findings with the constructs in 
the scales developed to measure stigma suggest that our 
findings are robust. 
The layering of AIDS stigma described by participants 
in our study has been reported previously in the literature 
(Reidpath & Chan, 2005; Ware, Wyatt, & Tugenberg, 2006) 
in relation to poverty (Masanjala, 2007), homosexuality 
(Dodds, 2006), gender (Mill, 2003), and ethnicity (Mill 
et al., 2009). Despite recognition of this phenomenon, 
there is a paucity of tools to measure layered stigma, and 
limited reports of the measurement of stigma simultane-
ously across several levels, and in particular the popula-
tion level (Nyblade, 2006). Campbell and Deacon (2006) 
argued that the overlapping nature of stigma for some 
individuals and groups makes it more difficult to exercise 
agency and resistance, and necessitates the assistance of 
external agents to resist stigma.
As a process, stigmatization is “linked to competi-
tion for power and the legitimization of social hierarchy 
and inequality” (Parker & Aggleton, 2003, p. 18). Par-
ticipants in the current study described disempowering 
health care practices when accessing health services. 
Power within the health care encounter generally, and 
with persons living with HIV specifically, can be an 
important social control mechanism. The dominant and 
powerful role of HCPs (in particular physicians) in the 
HIV testing experience (Worthington & Myers, 2003) 
and the treatment decisions of persons living with HIV 
(Taylor, 2001) have been documented in previous 
research. Taylor argued that the medical surveillance of 
an individual following an HIV-positive diagnosis is a 
“manifestation of paternalistic power in the guise of 
knowledge-seeking and in the name of beneficence” 
(p. 794). Worthington and Myers reported that for some 
HIV test recipients, anxiety was based on feelings of 
powerless and lack of control in negotiating the test 
experience. Health care providers also exert power in their 
role as gatekeepers to the health care system (Freund & 
McGuire, 1998).
Our findings suggest that stigma is primarily a mecha-
nism for social control; however, institutional responses 
to stigma might have positive outcomes for some margin-
alized communities by promoting empowerment and 
political activism (Cornish, 2006; Gilmore & Somerville, 
1994), thereby mitigating inequities. Institutions might 
create an environment that promotes stigmatization, but 
they might also “open up spaces for resistance and social 
change” (Campbell & Deacon, 2006, p. 414). Deacon 
(2006) cautioned that to ensure that both negative and 
positive responses to stigmatization are explored, stigma 
should not be defined in terms of discrimination. The ten-
dency to conflate the two terms has resulted in a lack of 
analytical clarity of the concept of stigma. Our analysis 
of the use of stigma as a social control mechanism with 
persons living with HIV provides greater clarity to the 
phenomenon of stigma. 
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Stigma plays a role in maintaining the status quo and 
balancing the social order. Campbell, Foulis, Maimane, 
and Sibiya maintained that stigma is a form of “social psy-
chological policing” (2005, p. 808) that punishes persons 
who challenge unequal power relations of gender, genera-
tion, and ethnicity. Parker and Aggleton argued that “to 
untie the threads of stigmatization and discrimination that 
bind those who are subjected to it is to call into question 
the very structures of equality and inequality in any social 
setting” (2003, p. 18). Similarly, Campbell and Deacon 
(2006) pointed out that the nonstigmatized have a sig-
nificant investment in maintaining the status quo because 
of the psychological and social benefits associated with 
“othering.” As a consequence, interventions to mitigate 
the impact of stigma are likely to prove challenging to 
implement.
The use of excessive or inconsistent infection control 
measures reported by participants has also been reported 
among African, HIV-positive migrants to England (Dodds, 
2006). In the current study, HCPs continuously assessed 
and redefined the practices and procedures that were in 
place to protect the public, while at the same time trying to 
provide an environment that was safe for the client and 
conducive to nondiscriminatory care. Health care provid-
ers found themselves at the interface between the interests 
of clients and the interests of public health. They attempted 
to build positive relationships as a means of bringing com-
passion to their work, despite the necessity of abiding by 
institutional infection control mechanisms such as uni-
versal precautions. In essence, the relationship with their 
clients was used as a means to offset institutional social 
control mechanisms. The dilemma described by HCPs 
about when to use gloves highlights the tensions they 
experienced in balancing the rights of the individual liv-
ing with HIV with the rights of the larger public. This ten-
sion was identified early in the epidemic (Bayer, 1989), 
and has been recently framed as a human rights issue 
(Mawar et al., 2005). Health care providers must balance 
the provision of humanistic, compassionate care with their 
professional responsibility to ensure the health of the public. 
To negotiate this balance, structural changes are required 
within institutions to enable HCPs to engage with clients 
in meaningful relationships. 
Clients balanced the risk of social shunning as a result 
of disclosure with their desire for good care. In managing 
their illness, PHAs and APHAs interfaced with many lev-
els of organizations and society, levels at which the expe-
rience of stigma was constantly shifting. They described 
the tensions experienced when using secrecy as a means 
to protect themselves from stigma. The need to balance 
secrecy with the necessity to disclose has been described 
by persons living with HIV in previous research (Dodds, 
2006; Greeff et al., 2009; Mill, 2003). Occasionally 
participants lost control over the decision to disclose 
when HCPs disclosed their status without their permis-
sion. This has been referred to as “mismanaged disclo-
sure” (Sandelowski, Lambe, & Barroso, 2004, p. 127).
Persons living with HIV and AIDS attempted to take 
control of their respective situation as a strategy to man-
age stigma. The process of balancing decisions about 
disclosure with the need for secrecy is an example of 
PHAs exerting social control. Joachim and Acorn (2000a) 
referred to this phenomenon as protective disclosure, and 
suggested that it is typically planned. The process of tak-
ing control is similar to the process of normalization that 
Joachim and Acorn (2000b) described in relation to liv-
ing with chronic illness. Normalization involves manag-
ing or adapting to a chronic illness. These authors argued 
that to understand the complexity of a chronic illness, it is 
important to view the illness not only through a stigma 
lens, but also through a normalization lens. 
The evolution of AIDS service organizations and the 
need for knowledgeable care, treatment, and support for 
persons living with HIV have created an institutionalized 
health care delivery system that might have inadvertently 
fueled stigmatization and created inequitable programs. 
The development of AIDS-specific programs, policies, 
and organizations, referred to as AIDS exceptionalism, 
can be traced to the early years of the AIDS epidemic and 
fear of the public health implications of AIDS. Whereas 
AIDS exceptionalism might have been an appropriate 
response to the emergence of HIV and AIDS, as the epi-
demic has progressed it has become increasingly difficult 
to defend the need for a policy response that is fundamen-
tally different than the response to other infectious dis-
eases (Bayer, 1991). Some authors have argued that AIDS 
exceptionalism should be challenged on the basis that it is 
unjust (Casarett & Lantos, 1998) and creates ethical issues 
related to access (Bayer, 1999). AIDS-specific services 
provide highly specialized and state-of-the-art services; 
however, the clients are labeled as soon as they walk 
through the door, contributing to the likelihood of stigma-
tization. Furthermore, the need for highly specialized 
knowledge for the management of AIDS leads to a wider 
gap between the specialist and the layperson (Freund & 
McGuire, 1998), the powerful and the powerless. 
Implications for Practice, 
Policy, and Research
Our findings illustrate the urgent need for the develop-
ment and implementation of interventions that manage, 
resist, or mitigate AIDS stigma and enhance health equity. 
Several authors (Campbell & Deacon, 2006; Campbell 
et al., 2007) have advocated multilevel interventions to 
address AIDS stigma. Campbell and colleagues (2007) 
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stressed the importance of complementary “top-down” 
and “bottom-up” interventions to address AIDS stigma, 
and the provision of “social space” for communities to 
critically examine issues related to HIV and AIDS. The 
realization that stigma is determined by a complex set of 
interrelated factors (e.g., individual, community, and 
political) results in the need for multilevel and multistrat-
egy intervention programs (Edwards, Mill, & Kothari, 
2004) across sectors. 
In consideration of Parker and Aggleton’s (2003) per-
spectives on social control mechanisms and power, HCPs 
and institutions must question whether a given policy 
related to HIV disclosure would yield the same type and 
level of control for clients who are marginalized vs. those 
who are not. In addition, the underlying social inequalities 
experienced by clients with HIV, and in particular those 
with layered stigma and those who have experienced 
social oppression, must be considered when identifying 
means to operationalize institutional HIV and AIDS poli-
cies. Our findings suggest that because stigma occurs 
within a social context where social control mecha-
nisms are in place, there are no stigma-free policies and 
procedures. Policymakers must ask whether a policy 
potentially produces or reproduces social inequalities 
(Parker & Aggleton), and what social order is maintained 
or modified as a result of a particular policy. This needs to 
be considered in relation not only to the client’s experiences 
of inequity in the health care organization, but also to his or 
her wider social and work experience. 
Our study findings suggest a number of propositions 
that require more exploration. Research is needed to exam-
ine the ways in which given policies such as universal pre-
cautions for HIV and AIDS exert social control and create 
inequities. The sources of power and the struggles for 
power that are part of social control mechanisms require 
additional elaboration. Various power hierarchies need to 
be considered here: those operational within the health 
care and social services institutions and within and between 
professional groups, and those operational within social 
structures. Research is also required to understand the 
intersection of societal attitudes, institutional structures, 
and individual experiences, including comparisons of the 
experiences of PHAs and APHAs. More historical and 
chronological information is needed to explore how social 
control mechanisms develop and how flexible or intransi-
gent they might be to shifting social views. Finally, institu-
tional ethnographies and embedded case studies might be 
useful methodologies to expose the inequities that contrib-
ute to the stigma experience and to explore layered stigma.
Conclusion
Our study contributes to an expanded theory of stigma 
and stigmatization as interrelated individual, social, and 
institutional processes. It might be difficult for PHAs and 
APHAs to resist and challenge the social control mecha-
nisms that reproduce stigma. To do so might limit their 
access to health care services. To do so might increase 
their vulnerability with respect to social support from 
family and HCPs. To do so might reduce the availability 
of treatment options. And to do so might fuel the flames 
of discrimination and magnify the experience of stigma. 
Resistance is much more than questioning a stigmatizing 
practice; it is questioning a much larger social order that 
creates inequities and crosses professions, institutions, 
and society at large.
Acknowledgments
We extend our thanks to the participants living with HIV and 
AIDS for their willingness to share very personal aspects of 
their lives. In addition, we thank the health care providers who 
took time from their busy schedules to share their perspectives 
on the topic. 
Declaration of Conflicting Interests
The authors declared no conflicts of interest with respect to 
authorship and/or publication of this article.
Funding
The authors disclosed receipt of the following financial support 
for the research and/or authorship of this article: Funding was 
received from the Canadian Institutes for Health Research.
References
Adelson, N. (2005). The embodiment of inequity: Health dis-
parities in aboriginal Canada. Canadian Journal of Public 
Health, 96, S45-S62. Retrieved from http://pubs.cpha.ca/
PDF/P24/22247.pdf
Aikins, A. D. (2006). Reframing applied disease stigma 
research: A multilevel analysis of diabetes stigma in Ghana. 
Journal of Community & Applied Social Psychology, 16(6), 
426-441. doi:10.1002/casp.892
Alonzo, A. A., & Reynolds, N. R. (1995). Stigma, HIV and 
AIDS: An exploration and elaboration of a stigma trajectory. 
Social Science & Medicine, 41(3), 303-315. doi:10.1016/
0277-9536(94)00384-6
Battiste, M., & Henderson, J. Y. (2000). Protecting indigenous 
knowledge and heritage. Saskatoon, SK, Canada: Purich.
Bayer, R. (1989). Private acts: Social consequences. New York: 
Macmillan. 
Bayer, R. (1991). Public health policy and the AIDS epidemic. 
An end to HIV exceptionalism? New England Journal of 
Medicine, 324(21), 1500-1504. Retrieved from http://content
.nejm.org/cgi/content/brief/324/21/1500
Bayer, R. (1999). Clinical progress and the future of HIV 
exceptionalism. Archives of Internal Medicine, 159(10), 
1042-1048. Retrieved from http://archinte.ama-assn.org/cgi/
reprint/159/10/1042
 at UNIV OF WESTERN ONTARIO on August 29, 2012qhr.sagepub.comDownloaded from 
Mill et al. 1481
Berger, B. E., Ferrans, C. E., & Lashley, F. R. (2001). Measur-
ing stigma in people with HIV: Psychometric assessment of 
the HIV stigma scale. Research in Nursing & Health, 24(6), 
518-529. doi:10.1002/nur.10011
Boulos, D., Yan, P., Schanzer, D., Remis, R. S., & Archibald, C. 
(2006). Estimates of HIV prevalence and incidence in Canada, 
2005. Canada Communicable Disease Report, 32(15), 165-174. 
Retrieved from http://www.atlantic.phac-aspc.gc.ca/publicat/
ccdr-rmtc/06pdf/cdr3215.pdf
Brandt, A. M. (1987). No magic bullet: A social history of vene-
real disease in the United States since 1880. New York: 
Oxford University.
Campbell, C., & Deacon, H. (2006). Unraveling the contexts 
of stigma: From internalization to resistance to change. 
Journal of Community & Applied Social Psychology, 
16(6), 411-417. doi:10.1002/casp.901
Campbell, C., Foulis, C. A., Maimane, S., & Sibiya, Z. (2005). 
“I have an evil child at my house”: Stigma and HIV/AIDS 
management in a South African community. American 
Journal of Public Health, 95(5), 808-815. doi:10.2105/
AJPH.2003.037499
Campbell, C., Nair, Y., Maimane, S., & Nicholson, J. (2007). 
‘Dying twice’: A multilevel model of the roots of AIDS stigma 
in two South African communities. Journal of Health Psy-
chology, 12(3), 403-416. doi:10.1177/1359105307076229
Casarett, D. J., & Lantos, J. D. (1998). Have we treated AIDS 
too well? Rationing and the future of AIDS exceptionalism. 
Annals of Internal Medicine, 128(9), 756-759. Retrieved 
from http://www.annals.org/content/128/9/756.abstract
Cornish, F. (2006). Challenging the stigma of sex work in 
India: Material context and symbolic change. Journal of 
Community & Applied Social Psychology, 16(6), 462-471. 
doi:10.1002/casp.894
Das, V. (2001). Stigma, contagion, defect: Issues in the anthro-
pology of public health. Retrieved from http://www.stigma 
conference.nih.gov/DasPaper.htm
Deacon, H. (2006). Towards a sustainable theory of health-
related stigma: Lessons from the HIV/AIDS literature. 
Journal of Community & Applied Social Psychology, 16(6), 
418-425. doi:10.1002/casp.900
Des Jarlais, D. C., Galea, S., Tracy, M., Tross, S., & Vlahov, D. 
(2006). Stigmatization of newly emerging infectious dis-
eases: AIDS and SARS. American Journal of Public Health, 
96(3), 561-567. doi:10.2105/AJPH.2004.054742
Dodds, C. (2006). HIV-related stigma in England: Experiences 
of gay men and heterosexual African migrants living with 
HIV. Journal of Community & Applied Social Psychology, 
16(6), 472-480. doi:10.1002/casp.895
Duffy, L. (2005). Suffering, shame, and silence: The stigma of 
HIV/AIDS. Journal of the Association of Nurses in AIDS 
Care, 16(1), 13-20. doi:10.1016/j.jana.2004.11.002
Edwards, N., Mill, J. E., & Kothari, A. R. (2004). Multiple inter-
vention research programs in community health. Canadian 
Journal of Nursing Research, 36(1), 41-54. Retrieved from 
http://www.ingentaconnect.com/content/mcgill/cjnr/2004/ 
00000036/00000001/art00005
Ermine, W., Sinclair, R., & Jeffrey, B. (2004). The ethics of 
research involving indigenous peoples. Report of the indige-
nous peoples’ health research centre to interagency advisory 
panel on research ethics. Saskatoon, SK, Canada: Indige-
nous Peoples’ Health Research Centre. 
Fee, E., & Parry, M. (2008). Jonathan Mann, HIV/AIDS, and 
human rights. Journal of Public Health Policy, 29(1), 54-71. 
doi:10.1057/palgrave.jphp.3200160
Freund, P. E. S., & McGuire, M. B. (1998). Health, illness and 
the social body: A critical sociology. Upper Saddle River, 
NJ: Prentice Hall.
Gilmore, N., & Somerville, M. A. (1994). Stigmatization, 
scapegoating and discrimination in sexually transmitted dis-
eases: Overcoming ‘them’ and ‘us.’ Social Science & Medi-
cine, 39(9), 1339-1358. doi:10.1016/0277-9536(94)90365-4 
Goffman, E. (1963). Stigma: Notes on the management of 
spoiled identity. Englewood Cliffs, NJ: Prentice-Hall.
Gracey, M., & King, M. (2009). Indigenous health part 1: 
Determinants and disease patterns. Lancet, 374, 65-75. 
doi:10.1016/S0140-6736(09)60914-4
Greeff, M., Phetlhu, R., Makoae, L. N., Dlamini, P. S.,Holzemer, 
W. L., Naidoo, J. R., . . . Chirwa, M. L. (2009). Disclosure of 
HIV status: Experiences and perceptions of persons living 
with HIV/AIDS and nurses involved in their care. 
Qualitative Health Research, 18, 311-324. doi:10.1177/
1049732307311118
Grove, K. A., & Kelly, D. P. (1997). ‘But nice girls don’t get 
it!’: Women, symbolic capital, and the social construction of 
AIDS. Journal of Contemporary Ethnography, 26(3), 317-338. 
doi:10.1177/089124197026003003
Gupta, G. R., Parkhurst, J. O., Ogden, J. A., Aggleton, P., & 
Mahal, A. (2008). Structural approaches to HIV prevention. Lan-
cet, 372(9640), 764-775. doi:10.1016/S0140-6736(08)60887-9
Hawkins, T. (2006). Appearance related side effects of HIV-1 treat-
ment. AIDS Patient Care & STDS, 20(1), 6-18. doi:10.1089/
apc.2006.20.6
Holzemer, W. L., Uys, L., Makoae, L., Stewart, A., Phetlhu, R., 
Dlamini, P. S., . . . Naidoo, J. R. (2007). A conceptual model of 
HIV/AIDS stigma from five African countries. Journal of 
Advanced Nursing, 58(6), 541-551. doi:10.1111/j.1365-2648
.2007.04244.x
Holzemer, W. L., Uys, L. R., Chirwa, M. L., Greeff, M., 
Makoae, L. N., Kohi, T. W., . . . Naidoo, J. R. (2007). Validation 
of the HIV/AIDS stigma instrument—PLWA (HASI-P). AIDS 
Care, 19(8), 1002-1012. doi:10.1080/09540120701245999
Howarth, C. (2006). Race as stigma: Positioning the stigmatized 
as agents, not objects. Journal of Community & Applied 
Social Psychology, 16(6), 442-451. doi:10.1002/casp.898
International Federation of Red Cross and Red Crescent Soci-
eties. (2004). Renewing our voice: Code of good practice 
for NGOs responding to HIV/AIDS. Geneva, Switzerland: 
Author.
 at UNIV OF WESTERN ONTARIO on August 29, 2012qhr.sagepub.comDownloaded from 
1482  Qualitative Health Research 20(11)
Joachim, G., & Acorn, S. (2000a). Stigma of visible and invisi-
ble chronic conditions. Journal of Advanced Nursing, 32(1), 
243-248. 
Joachim, G., & Acorn, S. (2000b). Living with chronic illness: 
The interface of stigma and normalization. Canadian Jour-
nal of Nursing Research, 32(3), 37-48. Retrieved from http://
www.ncbi.nlm.nih.gov/pubmed/11928132
Kalichman, S. C., Simbayi, L. C., Cloete, A., Mthembu, P. P., 
Mkhonta, R. N., & Ginindza, T. (2009). Measuring AIDS 
stigmas in people living with HIV/AIDS: The internal-
ized AIDS-related stigma scale. AIDS Care, 21(1), 87-93. 
doi:10.1080/09540120802032627
Kaufert, J., Commanda, L., Elias, B., Grey, R., Masuzumi, B., & 
Young, K. (2001). Community participation in health research 
ethics. In J. Oakes, R. Riewe, M. Bennett, & B. Chisholm 
(Eds.), Pushing the margins: Native and northern studies 
(pp. 50-61). Winnipeg, Canada: Native Studies Press.
King, M., Smith, A., & Gracey, M. (2009). Indigenous health 
part 2: The underlying causes of the health gap. Lancet, 374, 
76-85. doi:10.1016/S0140-6736(09)60827-8
Larkin, J., Flicker, S., Koleszar-Green, R., Mintz, S., Dagnino, M., 
& Mitchell, C. (2007). HIV risk, systemic inequities, and 
aboriginal youth: Widening the circle for HIV prevention 
programming. Canadian Journal of Public Health, 98(3), 
179-182. Retrieved from http://journal.cpha.ca/index.php/
cjph/article/viewFile/811/811
Mann, J. M., & Carballo, M. (1989). AIDS 1989: Social, cul-
tural and political aspects: Overview. AIDS, 3(Suppl. 1), 
S221-S223. doi:10.1097/00002030-198901001-00032
Masanjala, W. (2007). The poverty-HIV/AIDS nexus in Africa: 
A livelihood approach. Social Science & Medicine, 64(5), 
1032-1041. doi:10.1016/j.socscimed.2006.10.009
Mawar, N., Saha, S., Pandit, A., & Mahajan, U. (2005). The 
third phase of HIV pandemic: Social consequences of HIV/
AIDS stigma & discrimination & future needs. Indian Jour-
nal of Medical Research, 122(6), 471-484. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/16517997
May, K. A. (1991). Interview techniques in qualitative research: 
Concerns and challenges. In J. M. Morse (Ed.), Qualitative 
nursing research: A contemporary dialog. Thousand Oaks, 
CA: Sage.
Mill, J., Austin, W., Chaw-Kant, J., Dumont-Smith, C., 
Houston, S., Jackson, R., . . . Rientjes, F. (2007). The influ-
ence of stigma as access to health services by persons with 
HIV illness. Final Report. Edmonton, Alberta, Canada: 
University of Alberta. 
Mill, J., Edwards, N., Jackson, R., Austin, W., MacLean, L., 
& Reintjes, F. (2009). Accessing health services while liv-
ing with HIV: Intersections of stigma. Canadian Journal 
of Nursing Research 41(3), 168-185. Retrieved from http://
www.treeofcreation.ca/pdf/challenginglifestyles.pdf
Mill, J. E. (2001). I’m not a ‘basabasa’ woman: An explana-
tory model of HIV illness in Ghanaian women. Clini-
cal Nursing Research, 10(3), 254-274. Retrieved from 
http://www.ingentaconnect.com/content/mcgill/cjnr/2009/ 
00000041/00000003/art00012
Mill, J. E. (2003). Shrouded in secrecy: Breaking the news of 
HIV infection to Ghanaian women. Journal of Transcultural 
Nursing, 14(1), 6-16. doi:10.1177/1043659602238345
Morse, J. M. (1994). “Emerging from the data”: The cognitive 
processes of analysis in qualitative inquiry. In J. M. Morse 
(Ed.), Critical issues in qualitative research methods (pp. 23-43). 
Thousand Oaks, CA: Sage.
Murphy, E. (2001). Micro-level qualitative research. In N. Fulop, 
P. Allen, A. Clarke, & N. Black (Eds.), Studying organi-
zation and delivery of health services research methods. 
(pp. 40-55). London: Routledge.
Mwinituo, P. P., & Mill, J. E. (2006). Stigma associated with Gha-
naian caregivers of AIDS patients. Western Journal of Nursing 
Research, 28(4), 383-391. doi:10.1177/0193945906286602
Nyblade, L. C. (2006). Measuring HIV stigma: Existing knowl-
edge and gaps. Psychology, Health & Medicine, 11(3), 335-345. 
doi:10.1080/13548500600595178
Panos Institute. (1990). The 3rd epidemic: Repercussions of the 
fear of AIDS. London: Author.
Parker, R., & Aggleton, P. (2003). HIV and AIDS-related stigma 
and discrimination: A conceptual framework and implica-
tions for action. Social Science & Medicine, 57(1), 13-24. 
doi:10.1016/S0277-9536(02)00304-0
Paterson, B. L., Backmund, M., Hirsch, G., & Yim, C. (2007). 
The depiction of stigmatization in research about hepatitis 
C. International Journal on Drug Policy, 18(5), 364-373. 
doi:10.1016/j.drugpo.2007.02.004
Patterson, M., Jackson, R., & Edwards, N. (2006). Ethics in 
aboriginal research: Comments on paradigms, process and 
two worlds. Canadian Journal of Aboriginal Community-
Based HIV/AIDS Research, 1(Summer), 47-57. Retrieved 
from http://newsite.cbrc.net/attachments/067_CJACBR 
.pdf#page=55
Pearce, M. E., Christian, W. M., Patterson, K., Norris, K., 
Moniruzzaman, A., Craib, K., . . . Spittal, P. M. (2008). The 
Cedar Project: Historical trauma, sexual abuse and HIV 
risk among young aboriginal people who use injection and 
noninjection drugs in two Canadian cities. Social Science 
& Medicine, 66(11), 2185-2194. doi:10.1016/j.socscimed
.2008.03.034
Public Health Agency of Canada. (2007). HIV/AIDS epi updates, 
November 2007. Ottawa, ON, Canada: Surveillance and Risk 
Assessment Division, Centre for Infectious Disease Preven-
tion and Control. 
Reidpath, D. D., & Chan, K. Y. (2005). A method for the quan-
titative analysis of the layering of HIV-related stigma. AIDS 
Care, 17(4), 425-432. doi:10.1080/09540120412331319769
Sandelowski, M., Lambe, C., & Barroso, J. (2004). Stigma in 
HIV positive women. Journal of Nursing Scholarship, 36(2), 
122-128.
Schoepf, B. G. (1994). Action-research and empowerment in 
Africa. In B. E. Schneider & N. E. Stoller (Eds.), Women 
 at UNIV OF WESTERN ONTARIO on August 29, 2012qhr.sagepub.comDownloaded from 
Mill et al. 1483
resisting AIDS: Feminist strategies of empowerment 
(pp. 246-269). Philadelphia: Temple University Press.
Scott, A. (2009). Illness meanings of AIDS among women 
with HIV: Merging immunology and life experience. 
Qualitative Health Research, 19, 454-465. doi:10.1177/
1049732309332707
Shapiro, J. (2008). Walking a mile in their patients’ shoes: Empa-
thy and othering in medical students’ education. Philoso-
phy, Ethics, and Humanities in Medicine: PEHM, 3, 10-21. 
doi:10.1186/1747-5341-3-10
Siyan’Kela (2006). Stigma resource pack. Policy Project. Pre-
toria. Center for the Study of AIDS. Retrieved from http:// 
www.policyproject.com/pubs/countryreports/SA_SRP.pdf
Smylie, J., Kaplan-Myrth, N., Tait, C., Martin, C. M., 
Chartrand, L., Hogg, W., . . . Macaulay, A. C. (2004). Health 
sciences research and aboriginal communities: Pathway 
or pitfall? Journal of Obstetrics & Gynaecology Canada, 
26(3), 211-216. Retrieved from http://www.ncbi.nlm.nih.gov/
pubmed/15016333
Sontag, S. (2001). Illness as a metaphor and AIDS and it’s 
metaphors. New York, NY: Picador.
Statistics Canada. (2008). Aboriginal peoples in Canada in 
2006: Inuit, Métis and First Nations, 2006 census. Ottawa, 
ON, Canada: Author.
Stephens, C., Porter, J., Nettleton, C., & Willis, R. (2006). Dis-
appearing, displaced, and undervalued: A call to action for 
indigenous health worldwide. Lancet, 367(9527), 2019-2028. 
doi:10.1016/S0140-6736(06)68892-2
Taylor, B. (2001). HIV, stigma and health: Integration of theo-
retical concepts and the lived experiences of individuals. 
Journal of Advanced Nursing, 35(5), 792-798. doi:10.1046/
j.1365-2648.2001.01912.x
Ware, N. C., Wyatt, M. A., & Tugenberg, T. (2006). Social rela-
tionships, stigma and adherence to antiretroviral therapy 
for HIV/AIDS. AIDS Care, 18(8), 904-910. doi:10.1080/
09540120500330554
Weiss, M. G., & Ramakrishna, J. (2001). Interventions: 
Research on reducing stigma. Retrieved from http://www
.stigmaconference.nih.gov/WeissPaper.htm 
Wood, M., & Ross-Kerr, J. C. (2006). Basic steps in planning 
nursing research: From question to proposal (6th ed.). 
Sudbury, MA: Jones & Bartlett.
Worthington, C., & Myers, T. (2003). Factors underlying anxi-
ety in HIV testing: Risk perceptions, stigma, and the patient-
provider power dynamic. Qualitative Health Research, 13, 
636-655. doi:10.1177/1049732303013005004
Yang, L. H., Kleinman, A., Link, B. G., Phelan, J. C., Lee, S., 
& Good, B. (2007). Culture and stigma: Adding moral expe-
rience to stigma theory. Social Science & Medicine, 64(7), 
1524-1535. doi:10.1016/j.socscimed.2006.11.013
Bios
Judy E. Mill, RN, PhD, is a associate professor and associate 
dean, Global Health, Faculty of Nursing, University of Alberta, 
Edmonton, Alberta, Canada.
Nancy Edwards, RN, PhD, is a professor in the School of 
Nursing and in the Department of Epidemiology and Commu-
nity Medicine, University of Ottawa, Ottawa, Ontario, Canada. 
Nancy holds a Nursing Chair from the Canadian Health Services 
Research Foundation, the Canadian Institutes of Health Research, 
and the Government of Ontario.
Randy C. Jackson, BA, MA, is a PhD student in the school of 
Social Work, McMaster University, Hamilton, Ontario, Canada. 
Lynne MacLean, PhD, is a research specialist with the Popu-
lation Health Improvement Research Network, University of 
Ottawa, Ontario, Canada.
Jean Chaw-Kant, MSc, is a research project coordinator, Faculty 
of Nursing, University of Alberta, Edmonton, Alberta, Canada.
 at UNIV OF WESTERN ONTARIO on August 29, 2012qhr.sagepub.comDownloaded from 
